Clinical trial
An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
NCT03713424 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
- Lead sponsor
- University of Missouri-Columbia
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- March 26, 2019
- Completion date
- August 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.